(Q42913578)

11 November 2017

title

Celiprolol therapy for vascular Ehlers-Danlos syndrome (English)

1 reference

11 November 2017

main subject

Ehlers-Danlos syndrome

0 references

author name string

Benjamin S Brooke

series ordinal

1

1 reference

11 November 2017

language of work or name

English

0 references

publication date

7 September 2010

1 reference

11 November 2017

1 reference

11 November 2017

volume

376

1 reference

11 November 2017

issue

9751

1 reference

11 November 2017

page(s)

1443-1444

1 reference

Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

7 January 2021

Contemporary management of vascular complications associated with Ehlers-Danlos syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

7 January 2021

The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

7 January 2021

Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

1 reference

7 January 2021

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

7 January 2021

Aneurysm syndromes caused by mutations in the TGF-beta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

7 January 2021

TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

7 January 2021

Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

7 January 2021

Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

7 January 2021

Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-beta(1) gene in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

7 January 2021

Celiprolol Activates eNOS Through the PI3K-Akt Pathway and Inhibits VCAM-1 Via NF-κB Induced by Oxidative Stress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

7 January 2021

Circulating transforming growth factor-beta in Marfan syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961155-5

7 January 2021

10.1016/S0140-6736(10)61155-5

Identifiers

DOI

1 reference

11 November 2017

1 reference